Absolute Myocardial Perfusion Measurement in the Transplanted Heart

Status Completed

Clinical Trial Summary

The goal of this study is to detect AR and CR in the transplanted heart by quantitative assessment of myocardial blood flow and its constituents by myocardial contrast echocardiography (MCE). Further we investigate the collateral circulation in these patients.

Clinical Trial Description

Heart transplantation has become an accepted therapy for end-stage heart failure. Acute allograft rejection (AR) remains a major cause of mortality in heart transplant recipients. Chronic rejection (CR) determines the long-term prognosis after cardiac transplantation and is responsible for more than one third of late deaths. Different non-invasive methods have been evaluated for the detection of AR, but the gold standard remains endomyocardial biopsy (EMB).

Very little is known about the impact of CR on the collateral circulation in transplant patients. Since the collateral circulation of the heart is mainly part of the microcirculation, it can be hypothesized that it is less developed than in "normal" coronary atherosclerosis without microvascular lesions.

The quantification of CR with non-invasive techniques has remained difficult. In this context, there is a need for a reliable non-invasive test to avoid regularly invasive evaluation.

Based on the above considerations we propose that both AR and CR can be accurately detected and differentiated using non-invasive quantitative myocardial contrast echocardiography (MCE). ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Cardiac Transplantation

Clinical Trial Details

NCT number	NCT00414895
Study type	Observational
Source	University Hospital Inselspital, Berne
Contact
Status	Completed
Phase	N/A
Start date	December 2006
Completion date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02672683` - Non Invasive Detection of Cardiac Allograft Rejection by Circulating microRNAs
Completed	`NCT01017029` - Everolimus in de Novo Heart Transplant Recipients	Phase 4
Terminated	`NCT00338455` - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC	Phase 2
Completed	`NCT00170794` - Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.	Phase 3
Completed	`NCT00000412` - Osteoporosis Prevention After Heart Transplant	Phase 3
Completed	`NCT00716573` - Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure	Phase 4
Completed	`NCT02255123` - Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study	N/A
Active, not recruiting	`NCT00799188` - CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial	Phase 3
Terminated	`NCT00284531` - Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients	Phase 1/Phase 2
Active, not recruiting	`NCT05904678` - Anatomical and Functional Assessment of Ex-vivo Coronary Perfusion
Terminated	`NCT01235910` - Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation	Phase 4
Active, not recruiting	`NCT00581321` - Oral Water Ingestion in Heart Transplant Patients	N/A
Terminated	`NCT00166153` - Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept	N/A
Completed	`NCT03145441` - Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation	N/A